These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17105361)

  • 1. Review: clinical transfusion management in sickle cell disease.
    Rogers ZR
    Immunohematology; 2006; 22(3):126-31. PubMed ID: 17105361
    [No Abstract]   [Full Text] [Related]  

  • 2. Transfusion management in sickle cell disease.
    Wanko SO; Telen MJ
    Hematol Oncol Clin North Am; 2005 Oct; 19(5):803-26, v-vi. PubMed ID: 16214645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal Manual Exchange Transfusion Protocol for Sickle Cell Disease: A Retrospective Comparison of Two Comprehensive Care Centers in the United Kingdom and Canada.
    Mian HS; Ward R; Telfer P; Kaya B; Kuo KH
    Hemoglobin; 2015; 39(5):310-5. PubMed ID: 26114740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle Cell Disease: Monitoring, Current Treatment, and Therapeutics Under Development.
    Hoppe C; Neumayr L
    Hematol Oncol Clin North Am; 2019 Jun; 33(3):355-371. PubMed ID: 31030807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isovolemic hemodilution-red cell exchange for prevention of cerebrovascular accident in sickle cell anemia: the standard operating procedure.
    Matevosyan K; Anderson C; Sarode R
    J Clin Apher; 2012; 27(2):88-92. PubMed ID: 22302664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chiasm: transfusion practice versus patient blood management.
    Spahn DR; Shander A; Hofmann A
    Best Pract Res Clin Anaesthesiol; 2013 Mar; 27(1):37-42. PubMed ID: 23590914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial septal defect closure on cardiopulmonary bypass in a sickle cell anemia: role of hydroxyurea and partial exchange transfusion.
    Gosavi KS; Dash SK; Shah BN; Upasani CB
    Ann Card Anaesth; 2010; 13(2):145-7. PubMed ID: 20442545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manual erythroexchange for chronic transfusion therapy in patients with sickle cell syndromes unresponsive to hydroxyurea: a long-term follow-up.
    Carrara P; Balocco M; Pinto V; Olcese F; Soldà A; Strada P; Forni GL
    Am J Hematol; 2010 Dec; 85(12):974. PubMed ID: 21108330
    [No Abstract]   [Full Text] [Related]  

  • 9. Transfusion of sickle cells may be a therapeutic option for patients suffering metastatic disease.
    Goldberg JS
    Med Hypotheses; 2010 Apr; 74(4):629-30. PubMed ID: 20022432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regular automated red cell exchange transfusion in the management of pulmonary hypertension in sickle cell disease.
    Tsitsikas DA; Seligman H; Sirigireddy B; Odeh L; Nzouakou R; Amos RJ
    Br J Haematol; 2014 Dec; 167(5):707-10. PubMed ID: 25041505
    [No Abstract]   [Full Text] [Related]  

  • 11. Transfusion protocols for patients with sickle cell disease: working toward consensus?
    Meny GM
    Immunohematology; 2012; 28(1):1-2. PubMed ID: 22822518
    [No Abstract]   [Full Text] [Related]  

  • 12. Unpacking the utility of euvolemic automated transfusion in sickle cell disease.
    Baykara Y; Nixon C; Pavlovich A; Akgun Y
    Transfusion; 2024 Jul; 64(7):1381-1382. PubMed ID: 39010682
    [No Abstract]   [Full Text] [Related]  

  • 13. Indications for red cell transfusion in sickle cell disease.
    Ohene-Frempong K
    Semin Hematol; 2001 Jan; 38(1 Suppl 1):5-13. PubMed ID: 11206961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should we still be focused on red cell hemoglobin F as the principal explanation for the salutary effect of hydroxyurea in sickle cell disease?
    Segel GB; Simon W; Lichtman MA
    Pediatr Blood Cancer; 2011 Jul; 57(1):8-9. PubMed ID: 21480473
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transfusion and sickle cell disease: axes of transfusion safety optimization].
    Noizat-Pirenne F
    Transfus Clin Biol; 2014 May; 21(2):77-84. PubMed ID: 24811565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of sickle cell disease: recent advances and controversies.
    Castro O
    Br J Haematol; 1999 Oct; 107(1):2-11. PubMed ID: 10520020
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence gaps in the management of sickle cell disease: A summary of needed research.
    Savage WJ; Buchanan GR; Yawn BP; Afenyi-Annan AN; Ballas SK; Goldsmith JC; Hassell KL; James AH; John-Sowah J; Jordan L; Lottenberg R; Murad MH; Ortiz E; Tanabe PJ; Ware RE; Lanzkron SM
    Am J Hematol; 2015 Apr; 90(4):273-5. PubMed ID: 25639238
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia.
    Lebensburger J; Johnson SM; Askenazi DJ; Rozario NL; Howard TH; Hilliard LM
    Am J Hematol; 2011 May; 86(5):430-2. PubMed ID: 21523807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocytapheresis in pregnant patients with sickle hemoglobinopathies.
    Morrison JC; Douvas SG; Martin JN; Blake PG; Wiser WL; Durham MC; Morrison FS
    Am J Obstet Gynecol; 1984 Aug; 149(8):912-4. PubMed ID: 6465264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.